Schedule 13G ownership disclosure
OUTLOOK THERAPEUTICS INC
Common Stock, par value $0.01 per share · CUSIP: 69012T305
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 1,682,502.00 · Class: 6.4%
- KEVIN TANG
Shares: 1,682,502.00 · Class: 6.4%
- TANG CAPITAL PARTNERS, LP
Shares: 1,555,862.00 · Class: 5.9%
- TANG CAPITAL PARTNERS III, INC
Shares: 126,640.00 · Class: 0.5%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-002807
- Form type
- SCHEDULE 13G/A
- Filer
- Outlook Therapeutics, Inc.
- CIK
- CIK 1649989
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership